Wistar Research Identifies Mechanisms for Selective Multiple Sclerosis Treatment Strategy
28. Mai 2024 11:30 ET
|
The Wistar Institute
PHILADELPHIA, PA, May 28, 2024 (GLOBE NEWSWIRE) -- PHILADELPHIA — (May 28, 2024) — The Wistar Institute’s Paul M. Lieberman, Ph.D., and lab team led by senior staff scientist and first author,...
Hornet Therapeutics emerges from stealth with data published in Science demonstrating the first potential drug intervention for Epstein-Barr Virus (EBV) driven disease
23. Mai 2024 14:00 ET
|
Hornet Therapeutics
Press Release Hornet Therapeutics emerges from stealth with data published in Science demonstrating the first potential drug intervention for Epstein-Barr Virus (EBV) driven disease 4BIO Capital...
EBViously Presents Novel In-Vitro Data Demonstrating Potent Infection Prevention of its Vaccine Candidate EBV-001
04. Dezember 2023 04:00 ET
|
AKAMPION
Presentation at the World Vaccine Congress West Coast2023EBV-001 is designed for the prevention of Epstein-Barr Virus (EBV)-induced diseases via high titers of potent, neutralizing antibodiesNovel...
Epstein-Barr Virus Market Likely to Exhibit Substantial Growth by 2032, Examines DelveInsight | Key Players in the Market - Viracta, Atara, AlloVir, ModernaTX, Immunitas, Schrödinger, VelosBio, Takeda, Gilead, Merck
02. Oktober 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Epstein-Barr Virus Market Likely to Exhibit Substantial Growth by 2032, Examines DelveInsight | Key Players in the Market - Viracta, Atara, AlloVir,...
Wistar Researchers Discover Potential Target for Gastric Cancers Associated with Epstein-Barr Virus
22. August 2023 15:56 ET
|
The Wistar Institute
PHILADELPHIA, PA, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Now, scientists at The Wistar Institute have discovered a potential target for gastric cancers associated with Epstein-Barr Virus; study results...
Wistar Researchers Discover Potential Target for Gastric Cancers Associated with Epstein-Barr Virus
22. August 2023 15:02 ET
|
The Wistar Institute
PHILADELPHIA, PA, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Now, scientists at The Wistar Institute have discovered a potential target for gastric cancers associated with Epstein-Barr Virus; study results...
EBViously Announces First Details of Its EBV-001 Vaccine Candidate for the Prevention of Epstein-Barr Virus (EBV)-Induced Diseases
03. April 2023 04:00 ET
|
AKAMPION
Presentation at the World Vaccine Congress 2023EBV-infections associated with many cancers and multiple sclerosis Munich, Germany, April 3, 2023 – EBViously, a start-up developing novel vaccines...